2026

英文原著

  1. 1.Eto E, Maeda Y, Sonoda N, Nawata H, Takayanagi R, Shimabukuro M, Inoguchi T. Improved prognosis prediction of all-cause mortality and cardiovascular events by combined assessment of both ankle-brachial index and brachial-ankle pulse wave velocity in individuals with diabetes: The Kyushu prevention study for atherosclerosis, a prospective, multicenter survey. J Diabetes Investig in press. pubmed
  2. 2.Hashimoto K, Nakano H, Sakai A, Shimabukuro M, Kazama JJ, Ohira T, Ishikawa T, Nagao M, Okazaki K, Sato S, Yasumura S, Ohto H, Hosoya M, Go H. Effects of external radiation dose on pediatric peripheral blood components after the Great East Japan Earthquake: Fukushima Health Management Survey. Sci Rep 2026;16:19068. pubmed
  3. 3.Hayashi F, Ohira T, Takahashi A, Ueda Y, Nakano H, Okazaki K, Nagao M, Sato S, Maeda M, Miura I, Shimabukuro M, Sakai A, Kazama JJ, Ohto H, Yasumura S. Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima Health Management Survey. Sci Rep 2026;16:11141. pubmed
  4. 4.Kazama S, Hayashi F, Tanaka K, Sato S, Ueda Y, Okazaki K, Ohira T, Sakai A, Maeda M, Yabe H, Hosoya M, Takahashi A, Nakano H, Nagao M, Shimabukuro M, Ohto H, Yasumura S, Kazama JJ. Association of severe stress with the onset of chronic kidney disease after the Great East Japan Earthquake: The Fukushima Health Management Survey. Clin Exp Nephrol in press. pubmed
  5. 5.Ma E, Ohira T, Fukasawa M, Shirafuji A, Ohira H, Shimabukuro M. Trends in heart failure prevalence in post-disaster Fukushima residents 2015–2021. Sci Rep 2026;16:5222. pubmed
  6. 6.Ma E, et al. Seasonal variation in metabolic syndrome and its association with meteorological factors: a large population-based study in Fukushima, 2012–2022. J Epidemiol Glob Health in press pubmed
  7. 7.Oda A, Tanaka K, Kimura H, Saito H, Watanabe S, Asahi K, Shimabukuro M, Watanabe T, Kazama JJ. eGFR slope and risk of cardiovascular, kidney, and mortality outcomes in hypertension: a longitudinal cohort study. J Hypertens 2026;44:1230–1237. pubmed
  8. 8.Okamoto S, et al. Brown rice bran fermented with Aspergillus oryzae attenuates cognitive decline in aged mice accompanied by induction of immediate-early genes in the hippocampus. J Food Bioactives in press.
  9. 9.Saito H, Tanaka K, Kimura H, Watanabe S, Oda A, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Resting heart rate and incident CKD among individuals with CKD risk factors. Nephrology 2026;31:e70223. pubmed
  10. 10.Tanabe H, Kono T, Saito H, Maimaituxun G, Tanaka K, Kazama JJ, Shimabukuro M. Peri-renal and sinus fat accumulation and diabetic kidney disease in type 2 diabetes: A Japanese cohort study. Diabetes Res Clin Pract 2026;232:113074. pubmed
  11. 11.Tanabe H, Shimajiri Y, Shiroma K, Higa M, Masuzaki H, Shimabukuro M. Unequal distribution of plasma glucagon levels among clustering-based diabetes subtypes: a Japanese cohort. J Clin Endocrinol Metab 2026;111:e1662–e1671. pubmed
  12. 12.Tanaka A, Imai T, Vaduganathan M, Okada Y, Sonoda S, Torimoto K, Suwa S, Teragawa H, Miyazono M, Fukuda M, Yonezu K, Takahashi N, Yoshida Y, Tanaka K, Shimabukuro M, Hotta Y, Moroi M, Niikura H, Kida K, Yokota K, Fukuda D, Tanabe K, Horiuchi Y, Toyoda S, Taguchi I, Yoshida H, Miyoshi T, Nangaku M, Shibata H, Node K. Randomized trial of finerenone on urinary albumin-to-creatinine ratio in type 2 diabetes mellitus and CKD. Kidney Int Rep 2026;11:7106546. pubmed
  13. 13.Tanaka K, Kimura H, Saito H, Watanabe S, Oda A, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Platelet indices and incident CKD in high-risk individuals. Clin Exp Nephrol in press. pubmed
  14. 14.Watanabe G, Horita S, Moriya RF, Masuishi Y, Misaka S, Taira S, Shimomura K, Shimabukuro M, Kazama JJ. Canagliflozin-induced renal glutathione distribution mapping in non-diabetic male rat kidneys. Physiol Rep in press. pubmed
  15. 15.Watanabe-Shimoji K, Tanabe H, Ohsugi M, Kawakami E, Tanaka K, Kazama JJ, Ueki K, Shimabukuro M, for the J-DREAMS Investigators. Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS Registry. Diabetologia 2026;69:883–899. pubmed
  16. 16.Watanabe S, Tanaka K, Kimura H, Saito H, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Association between mean platelet volume and kidney events in patients with type 2 diabetes mellitus. J Diabetes Investig 2026;17:51–59. pubmed

英文総説

  1. 1.Shimabukuro M, Tanabe H, Nomura K, Matsuo M, Sakaue H. Response to comment on Tanabe et al. Prediction of sarcopenia onset in type 2 diabetes using urinary titin levels: a Japanese prospective cohort study. Diabetes Care 2026;49:e6. pubmed

英文症例

和文著書

和文総説

ページの先頭へ戻る